Uterine diffuse large B-cell lymphoma (DLBCL) is a rare clinical condition. Most studies for uterine DLBCL are derived from case reports and series. Our main objective was to present a new case while also investigating the demographic, clinical characteristics, and survival of women with primary uterine DLBCL as compared to non-uterine DLBCL using the Surveillance, Epidemiology, and End Results incidence database. We queried the Surveillance, Epidemiology, and End Results database for women aged 18 years or older with a diagnosis of primary DLBCL from 1975 to 2017. The most common site of primary uterine DLBCL is the cervix uteri not otherwise specified, followed by endometrium, uterus not otherwise specified, corpus uteri, myometrium and isthmus uteri. Non-uterine DLBCL cases tend to be older than uterine DLBCL cases. Uterine DLBCL is most common among women aged 40 to 64 years. Patients with uterine DLBCL showed greater survival than non-uterine DLBCL patients, and patients treated in the rituximab era also exhibited a survival benefit. Both the elderly and African American cohorts experienced worse overall survival.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500583 | PMC |
| http://dx.doi.org/10.1097/MD.0000000000027359 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Primary uterine non-Hodgkin's lymphoma:a rare case report and review of the literature.
Front Oncol
December 2024
Department of Radiology, the Affiliated Hospital of inner Mongolia Medical University, Hohhot, China.
Primary uterine non-Hodgkin lymphoma (NHL) is rarely reported, as its incidence is extremely low. We describe a 72 year old patient with primary uterine non-Hodgkin's lymphoma stage IV, diffuse B-cell large cells, who responded well to cytotoxic chemotherapy (R-CHOP). Radiological investigations exhibited certain characteristics, including magnetic resonance T2 weighted imaging, enhanced scanning, diffusion weighted imaging and apparent diffusion coefficient values.
View Article and Find Full Text PDFSecondary CNS involvement (SCNSL) is a rare manifestation of diffuse large B-cell lymphoma (DLBCL) with a poor prognosis. We present updated data from a nationwide study on the incidence and clinical characteristics of SCNSL. The incidence of SCNSL was calculated considering death or relapse without SCNSL as competing risks.
View Article and Find Full Text PDFSuperior prognostic accuracy of FIGO staging system in primary female genital tract lymphomas: A retrospective study (IELSG35).
Hematol Oncol
November 2024
Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Article Synopsis
- Primary lymphoma of the female genital tract (PLFGT) is an uncommon type of lymphoma, with a study involving 60 women revealing that many cases were diagnosed around their early 50s.
- The uterus and ovaries were the most frequently affected sites, and diffuse large B-cell lymphoma (DLBCL) was the predominant subtype found in the majority of patients.
- The study indicated a median overall survival of approximately 13 years for DLBCL patients, with advanced disease stage correlating to a poorer prognosis, while CNS relapses were notably linked to patients with ovarian involvement who did not receive prophylactic treatment.
Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group.
Hematol Oncol
September 2024
Department of Hematology and Bone Marrow Transplantation, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Involvement of female genital track (FGT) by diffuse large B cell lymphoma (DLBCL) represents an extremely rare diagnosis. Especially data regarding early-stage disease (i.e.
View Article and Find Full Text PDFA retrospective study at a single center examining risk factors associated with central nervous system involvement in individuals diagnosed with diffuse large B-cell lymphoma.
Clin Neurol Neurosurg
September 2024
Department of Oncology, Banan Hospital affiliated to Chongqing Medical University, Chongqing 404100, China.
Objective: The aim of this study is to identify risk factors contributing to central nervous system (CNS) invasion and to validate the suitability of the Central Nervous System International Prognostic Index (CNS-IPI) for individuals afflicted with diffuse large B-cell lymphoma (DLBCL).
Methods: Based on the presence or absence of CNS invasion, 365 patients were stratified into two groups: the CNS group and the non-CNS group. The clinical data of the patients were retrospectively analyzed using univariate and multivariate analysis, and the differences in survival curves were compared.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!